Related Experiment Video
Updated: Dec 5, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective
Danilo Menichelli1, Angela Sciacqua2, Roberto Cangemi3
1I Clinica Medica, Atherothrombosis Centre, Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Insights
Left atrial diameter (LAd) predicts cardiovascular events in atrial fibrillation (AF) patients. This simple measurement offers prognostic value regardless of AF pattern, aiding risk stratification for cardiovascular outcomes.
Area of Science:
- Cardiology
- Echocardiography
- Atrial Fibrillation Research
Background:
- Conflicting evidence exists regarding the association between atrial fibrillation (AF) patterns (persistent/permanent vs. paroxysmal) and ischemic event risk.
- The role of left atrial diameter (LAd) in modulating cardiovascular outcomes across different AF patterns requires clarification.
Purpose of the Study:
- To investigate whether left atrial diameter (LAd) influences the risk of cardiovascular outcomes in patients with non-valvular atrial fibrillation.
- To determine if LAd provides prognostic information independently of AF pattern (paroxysmal AF vs. persistent/permanent AF).
Main Methods:
- Prospective multicenter observational study including 1,252 non-valvular AF patients.
- Left atrial anteroposterior diameter (LAd) measured via transthoracic echocardiography.
- Endpoints included cardiovascular events (CVEs), major adverse cardiac events (MACE), and cardiovascular death over a mean follow-up of 42.2 months.
Main Results:
- Patients with persistent/permanent AF showed a higher proportion of LAd above the median (≥44 mm) compared to paroxysmal AF (59.5% vs. 37.5%, P < .001).
- Higher LAd was significantly associated with increased rates of CVEs, MACE, and cardiovascular death (log-rank tests, P < .001 for all).
- Multivariable analysis confirmed LAd above the median as an independent predictor for CVEs (HR 1.569), MACE (HR 1.858), and CV death (HR 2.106), irrespective of AF pattern.
Conclusions:
- Left atrial diameter (LAd) is a readily obtainable parameter in AF patients.
- LAd provides significant prognostic information regarding the risk of cardiovascular events, MACE, and cardiovascular death.
- The prognostic value of LAd is consistent across both paroxysmal and persistent/permanent atrial fibrillation patterns.
Background:
There are conflicting evidence on the association between atrial fibrillation (AF) pattern, such as persistent/permanent (Pers/Perm) and paroxysmal (PAF) AF and risk of ischemic events. We investigated if left atrial diameter (LAd) may affect the risk of cardiovascular outcomes according to AF pattern.
Methods:
Prospective multicenter observational including 1,252 non-valvular AF patients (533 PAF and 719 Pers/Perm AF). Study endpoints were cardiovascular events (CVEs), major adverse cardiac events (MACE) and CV death. LA anteroposterior diameter (LAd) was obtained by transthoracic echocardiography.
Results:
Pers/Perm AF patients had a higher proportion of LAd above median than PAF (≥44 mm, 59.5% vs 37.5% respectively, P < .001). In a mean follow-up of 42.2 ± 31.0 months (4,315 patients/year) 179 CVEs (incidence rate [IR] 4.2%/year), 133 MACE (IR 3.1%/year), and 97 CV deaths (IR 2.2%/year) occurred. Compared to patients with LAd below median, those with LAd above the median had a higher rate of CVEs (log-rank test, P < .001), MACE (log-rank test P < .001), and CV death (log-rank test P < .001). Multivariable Cox regression analysis showed that LAd above the median was associated with CVEs, (HR 1.569, 95% CI 1.129-2.180, P = .007) MACE (HR 1.858, 95% CI 1.257-2.745, P = .002) and CV death (HR 2.106, 95% CI 1.308-3.390, P = .002). The association between LAd and outcomes was evident both in PAF and Pers/Perm AF patients. No association between AF pattern and outcomes was found.
Conclusion:
LAd is a simple parameter that can be obtained in virtually all AF patients and can provide prognostic information on the risk of CVEs, MACE and CV death regardless of AF pattern.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests

